{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:55:19Z","timestamp":1790006119857,"version":"4.0.1"},"reference-count":83,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,10,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>T-cell large granular lymphocyte (T-LGL) leukemia is a clonal lymphoproliferation of cytotoxic T cells (CTLs) associated with cytopenias. T-LGL proliferation seems to be triggered\/sustained by antigenic drive; it is likely that hematopoietic progenitors are the targets in this process. The antigen-specific portion of the T-cell receptor (TCR), the variable beta (VB)\u2013chain complementarity-determining region 3 (CDR3), can serve as a molecular signature (clonotype) of a T-cell clone. We hypothesized that clonal CTL proliferation develops not randomly but in the context of an autoimmune response. We identified the clonotypic sequence of T-LGL clones in 60 patients, including 56 with known T-LGL and 4 with unspecified neutropenia. Our method also allowed for the measurement of clonal frequencies; a decrease in or loss of the pathogenic clonotype and restoration of the TCR repertoire was found after hematologic remission. We identified 2 patients with identical immunodominant CDR3 sequence. Moreover, we found similarity between multiple immunodominant clonotypes and codominant as well as a nonexpanded, \u201csupporting\u201d clonotypes. The data suggest a nonrandom clonal selection in T-LGL, possibly driven by a common antigen. In contrast, the physiologic clonal CTL repertoire is highly diverse and we were not able to detect any significant clonal sharing in 26 healthy controls.<\/jats:p>","DOI":"10.1182\/blood-2004-10-4045","type":"journal-article","created":{"date-parts":[[2005,5,25]],"date-time":"2005-05-25T02:48:24Z","timestamp":1116989304000},"page":"2769-2780","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":86,"title":["Pathologic clonal cytotoxic T-cell responses: nonrandom nature of the T-cell\u2013receptor restriction in large granular lymphocyte leukemia"],"prefix":"10.1182","volume":"106","author":[{"given":"Marcin W.","family":"Wlodarski","sequence":"first","affiliation":[{"name":"From the Experimental Hematology and Hematopoiesis Section, Taussig Cancer Center, and the Department of Clinical Pathology, Cleveland Clinic Foundation, Cleveland, OH; Institute of Medical Immunology, Charite Medical School, Berlin, Germany; Penn State Cancer Institute, Hershey, PA; and Hematology Branch, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"O'Keefe","sequence":"additional","affiliation":[{"name":"From the Experimental Hematology and Hematopoiesis Section, Taussig Cancer Center, and the Department of Clinical Pathology, Cleveland Clinic Foundation, Cleveland, OH; Institute of Medical Immunology, Charite Medical School, Berlin, Germany; Penn State Cancer Institute, Hershey, PA; and Hematology Branch, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan C.","family":"Howe","sequence":"additional","affiliation":[{"name":"From the Experimental Hematology and Hematopoiesis Section, Taussig Cancer Center, and the Department of Clinical Pathology, Cleveland Clinic Foundation, Cleveland, OH; Institute of Medical Immunology, Charite Medical School, Berlin, Germany; Penn State Cancer Institute, Hershey, PA; and Hematology Branch, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio M.","family":"Risitano","sequence":"additional","affiliation":[{"name":"From the Experimental Hematology and Hematopoiesis Section, Taussig Cancer Center, and the Department of Clinical Pathology, Cleveland Clinic Foundation, Cleveland, OH; Institute of Medical Immunology, Charite Medical School, Berlin, Germany; Penn State Cancer Institute, Hershey, PA; and Hematology Branch, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"From the Experimental Hematology and Hematopoiesis Section, Taussig Cancer Center, and the Department of Clinical Pathology, Cleveland Clinic Foundation, Cleveland, OH; Institute of Medical Immunology, Charite Medical School, Berlin, Germany; Penn State Cancer Institute, Hershey, PA; and Hematology Branch, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilka","family":"Warshawsky","sequence":"additional","affiliation":[{"name":"From the Experimental Hematology and Hematopoiesis Section, Taussig Cancer Center, and the Department of Clinical Pathology, Cleveland Clinic Foundation, Cleveland, OH; Institute of Medical Immunology, Charite Medical School, Berlin, Germany; Penn State Cancer Institute, Hershey, PA; and Hematology Branch, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Thomas P.","family":"Loughran","sequence":"additional","affiliation":[{"name":"From the Experimental Hematology and Hematopoiesis Section, Taussig Cancer Center, and the Department of Clinical Pathology, Cleveland Clinic Foundation, Cleveland, OH; Institute of Medical Immunology, Charite Medical School, Berlin, Germany; Penn State Cancer Institute, Hershey, PA; and Hematology Branch, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslaw P.","family":"Maciejewski","sequence":"additional","affiliation":[{"name":"From the Experimental Hematology and Hematopoiesis Section, Taussig Cancer Center, and the Department of Clinical Pathology, Cleveland Clinic Foundation, Cleveland, OH; Institute of Medical Immunology, Charite Medical School, Berlin, Germany; Penn State Cancer Institute, Hershey, PA; and Hematology Branch, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021215293697000_REF1","doi-asserted-by":"crossref","unstructured":"Lamy T, Loughran TP Jr. Current concepts: large granular lymphocyte leukemia. Blood Rev. 1999;13: 230-240.","DOI":"10.1054\/blre.1999.0118"},{"key":"2020021215293697000_","doi-asserted-by":"crossref","unstructured":"Kuzushima K, Hoshino Y, Fujii K, et al. Rapid determination of Epstein-Barr virus-specific CD8(+) T-cell frequencies by flow cytometry. Blood. 1999;94: 3094-3100.","DOI":"10.1182\/blood.V94.9.3094"},{"key":"2020021215293697000_","doi-asserted-by":"crossref","unstructured":"Gillespie GM, Wills MR, Appay V, et al. Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors. J Virol. 2000;74: 8140-8150.","DOI":"10.1128\/JVI.74.17.8140-8150.2000"},{"key":"2020021215293697000_","doi-asserted-by":"crossref","unstructured":"Bousso P, Kourilsky P. A clonal view of alphabeta T cell responses. Semin Immunol. 1999;11: 423-431.","DOI":"10.1006\/smim.1999.0200"},{"key":"2020021215293697000_","doi-asserted-by":"crossref","unstructured":"Callan MF, Tan L, Annels N, et al. Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo. J Exp Med. 1998;187: 1395-1402.","DOI":"10.1084\/jem.187.9.1395"},{"key":"2020021215293697000_","doi-asserted-by":"crossref","unstructured":"Maryanski JL, Jongeneel CV, Bucher P, Casanova JL, Walker PR. Single-cell PCR analysis of TCR repertoires selected by antigen in vivo: a high magnitude CD8 response is comprised of very few clones. Immunity. 1996;4: 47-55.","DOI":"10.1016\/S1074-7613(00)80297-6"},{"key":"2020021215293697000_REF7","doi-asserted-by":"crossref","unstructured":"Mandruzzato S, Rossi E, Bernardi F, et al. Large and dissimilar repertoire of Melan-A\/MART-1-specific CTL in metastatic lesions and blood of a melanoma patient. J Immunol. 2002;169: 4017-4024.","DOI":"10.4049\/jimmunol.169.7.4017"},{"key":"2020021215293697000_REF8","doi-asserted-by":"crossref","unstructured":"Klein J, Sato A. The HLA system: first of two parts. N Engl J Med. 2000;343: 702-709.","DOI":"10.1056\/NEJM200009073431006"},{"key":"2020021215293697000_","doi-asserted-by":"crossref","unstructured":"Klein J, Sato A. The HLA system: second of two parts. N Engl J Med. 2000;343: 782-786.","DOI":"10.1056\/NEJM200009143431106"},{"key":"2020021215293697000_REF10","doi-asserted-by":"crossref","unstructured":"Loughran TP Jr. Clonal diseases of large granular lymphocytes. Blood. 1993;82: 1-14.","DOI":"10.1182\/blood.V82.1.1.bloodjournal8211"},{"key":"2020021215293697000_REF11","doi-asserted-by":"crossref","unstructured":"Gorski J, Yassai M, Zhu X, et al. Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping: correlation with immune status. J Immunol. 1994;152: 5109-5119.","DOI":"10.4049\/jimmunol.152.10.5109"},{"key":"2020021215293697000_REF12","doi-asserted-by":"crossref","unstructured":"Pannetier C, Even J, Kourilsky P. T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol Today. 1995;16: 176-181.","DOI":"10.1016\/0167-5699(95)80117-0"},{"key":"2020021215293697000_REF13","doi-asserted-by":"crossref","unstructured":"Arstila TP, Casrouge A, Baron V, et al. Diversity of human alpha beta T cell receptors. Science. 2000;288: 1135.","DOI":"10.1126\/science.288.5469.1135a"},{"key":"2020021215293697000_REF14","doi-asserted-by":"crossref","unstructured":"Silins SL, Cross SM, Krauer KG, et al. A functional link for major TCR expansions in healthy adults caused by persistent Epstein-Barr virus infection. J Clin Invest. 1998;102: 1551-1558.","DOI":"10.1172\/JCI4225"},{"key":"2020021215293697000_","doi-asserted-by":"crossref","unstructured":"Maini MK, Gudgeon N, Wedderburn LR, Rickinson AB, Beverley PC. Clonal expansions in acute EBV infection are detectable in the CD8 and not the CD4 subset and persist with a variable CD45 phenotype. J Immunol. 2000;165: 5729-5737.","DOI":"10.4049\/jimmunol.165.10.5729"},{"key":"2020021215293697000_REF16","doi-asserted-by":"crossref","unstructured":"Woitas RP, Sippel M, Althausen EM, et al. Differential expansion of T-cell receptor variable beta subsets after antigenic stimulation in patients with different outcomes of hepatitis C infection. Immunology. 2002;106: 419-427.","DOI":"10.1046\/j.1365-2567.2002.01437.x"},{"key":"2020021215293697000_","doi-asserted-by":"crossref","unstructured":"Risitano AM, Maciejewski JP, Green S, et al. Invivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing. Lancet. 2004;364: 355-364.","DOI":"10.1016\/S0140-6736(04)16724-X"},{"key":"2020021215293697000_REF18","doi-asserted-by":"crossref","unstructured":"Zeng W, Maciejewski JP, Chen G, Young NS. Limited heterogeneity of T cell receptor BV usage in aplastic anemia. J Clin Invest. 2001;108: 765-773.","DOI":"10.1172\/JCI200112687"},{"key":"2020021215293697000_REF19","doi-asserted-by":"crossref","unstructured":"Plasilova M, Risitano A, Maciejewski JP. Application of the molecular analysis of the T cell receptor repertoire in the study of immune-mediated hematologic disease. Hematol J. 2003;8: 173-181.","DOI":"10.1080\/1024533031000107505"},{"key":"2020021215293697000_REF20","doi-asserted-by":"crossref","unstructured":"Padovan E, Casorati G, Dellabona P, et al. Expression of two T cell receptor alpha chains: dual receptor T cells. Science. 1993;262: 422-424.","DOI":"10.1126\/science.8211163"},{"key":"2020021215293697000_REF21","doi-asserted-by":"crossref","unstructured":"Davis MM, Bjorkman PJ. T-cell antigen receptor genes and T-cell recognition. Nature. 1988;334: 395-402.","DOI":"10.1038\/334395a0"},{"key":"2020021215293697000_REF22","doi-asserted-by":"crossref","unstructured":"Borg NA, Ely LK, Beddoe T, et al. The CDR3 regions of an immunodominant T cell receptor dictate the `energetic landscape' of peptide-MHC recognition. Nat Immunol. 2005;6: 171-180.","DOI":"10.1038\/ni1155"},{"key":"2020021215293697000_REF23","doi-asserted-by":"crossref","unstructured":"Garboczi DN, Ghosh P, Utz U, et al. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature. 1996;384: 134-141.","DOI":"10.1038\/384134a0"},{"key":"2020021215293697000_REF24","doi-asserted-by":"crossref","unstructured":"Hedrick SM, Engel I, McElligott DL, et al. Selection of amino acid sequences in the beta chain of the T cell antigen receptor. Science. 1988;239: 1541-1544.","DOI":"10.1126\/science.2832942"},{"key":"2020021215293697000_REF25","doi-asserted-by":"crossref","unstructured":"Kalergis AM, Nathenson SG. Altered peptide ligand-mediated TCR antagonism can be modulated by a change in a single amino acid residue within the CDR3 beta of an MHC class I-restricted TCR. J Immunol. 2000;165: 280-285.","DOI":"10.4049\/jimmunol.165.1.280"},{"key":"2020021215293697000_","doi-asserted-by":"crossref","unstructured":"Goyarts EC, Vegh Z, Kalergis AM, et al. Point mutations in the beta chain CDR3 can alter the T cell receptor recognition pattern on an MHC class I\/peptide complex over a broad interface area. Mol Immunol. 1998;35: 593-607.","DOI":"10.1016\/S0161-5890(98)00056-X"},{"key":"2020021215293697000_","doi-asserted-by":"crossref","unstructured":"Engel I, Hedrick SM. Site-directed mutations in the VDJ junctional region of a T cell receptor beta chain cause changes in antigenic peptide recognition. Cell. 1988;54: 473-484.","DOI":"10.1016\/0092-8674(88)90068-2"},{"key":"2020021215293697000_REF28","doi-asserted-by":"crossref","unstructured":"Huang JC, Ober RJ, Ward ES. The central residues of a T cell receptor sequence motif are key determinants of autoantigen recognition in murine experimental autoimmune encephalomyelitis. Eur J Immunol. 2005;35: 299-304.","DOI":"10.1002\/eji.200425501"},{"key":"2020021215293697000_REF29","doi-asserted-by":"crossref","unstructured":"Sourdive DJ, Murali-Krishna K, Altman JD, et al. Conserved T cell receptor repertoire in primary and memory CD8 T cell responses to an acute viral infection. J Exp Med. 1998;188: 71-82.","DOI":"10.1084\/jem.188.1.71"},{"key":"2020021215293697000_REF30","doi-asserted-by":"crossref","unstructured":"Peggs K, Verfuerth S, Pizzey A, et al. Characterization of human cytomegalovirus peptide-specific CD8(+) T-cell repertoire diversity following in vitro restimulation by antigen-pulsed dendritic cells. Blood. 2002;99: 213-223.","DOI":"10.1182\/blood.V99.1.213"},{"key":"2020021215293697000_REF31","doi-asserted-by":"crossref","unstructured":"Hirokawa M, Matsutani T, Saitoh H, et al. Distinct TCRAV and TCRBV repertoire and CDR3 sequence of T lymphocytes clonally expanded in blood and GVHD lesions after human allogeneic bone marrow transplantation. Bone Marrow Transplant. 2002;30: 915-923.","DOI":"10.1038\/sj.bmt.1703730"},{"key":"2020021215293697000_REF32","doi-asserted-by":"crossref","unstructured":"Bourcier KD, Lim DG, Ding YH, et al. Conserved CDR3 regions in T-cell receptor (TCR) CD8(+)T cells that recognize the Tax11\u201319\/HLA-A*0201 complex in a subject infected with human T-cell leukemia virus type 1: relationship of T-cell fine specificity and major histocompatibility complex\/peptide\/TCR crystal structure. J Virol. 2001;75: 9836-9843.","DOI":"10.1128\/JVI.75.20.9836-9843.2001"},{"key":"2020021215293697000_","doi-asserted-by":"crossref","unstructured":"Matsumoto I, Tsubota K, Satake Y, et al. Common T cell receptor clonotype in lacrimal glands and labial salivary glands from patients with Sjogren's syndrome. J Clin Invest. 1996;97: 1969-1977.","DOI":"10.1172\/JCI118629"},{"key":"2020021215293697000_REF34","doi-asserted-by":"crossref","unstructured":"Sensi M, Salvi S, Castelli C, et al. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone. J Exp Med. 1993;178: 1231-1246.","DOI":"10.1084\/jem.178.4.1231"},{"key":"2020021215293697000_REF35","doi-asserted-by":"crossref","unstructured":"Lamy T, Loughran TP Jr. Clinical features of large granular lymphocyte leukemia. Semin Hematol. 2003;40: 185-195.","DOI":"10.1016\/S0037-1963(03)00133-1"},{"key":"2020021215293697000_REF36","doi-asserted-by":"crossref","unstructured":"Bible KC, Tefferi A. Cyclosporine A alleviates severe anaemia associated with refractory large granular lymphocytic leukaemia and chronic natural killer cell lymphocytosis. Br J Haematol. 1996;93: 406-408.","DOI":"10.1046\/j.1365-2141.1996.5061047.x"},{"key":"2020021215293697000_","doi-asserted-by":"crossref","unstructured":"Rose MG, Berliner N. T-cell large granular lymphocyte leukemia and related disorders. Oncologist. 2004;9: 247-258.","DOI":"10.1634\/theoncologist.9-3-247"},{"key":"2020021215293697000_REF38","doi-asserted-by":"crossref","unstructured":"Berliner N, Duby AD, Linch DC, et al. T cell receptor gene rearrangements define a monoclonal T cell proliferation in patients with T cell lymphocytosis and cytopenia. Blood. 1986;67: 914-918.","DOI":"10.1182\/blood.V67.4.914.914"},{"key":"2020021215293697000_REF39","doi-asserted-by":"crossref","unstructured":"Langerak AW, van den BR, Wolvers-Tettero IL, et al. Molecular and flow cytometric analysis of the Vbeta repertoire for clonality assessment in mature TCRalphabeta T-cell proliferations. Blood. 2001;98: 165-173.","DOI":"10.1182\/blood.V98.1.165"},{"key":"2020021215293697000_REF40","doi-asserted-by":"crossref","unstructured":"Lima M, Almeida J, Santos AH, et al. Immunophenotypic analysis of the TCR-Vbeta repertoire in 98 persistent expansions of CD3(+)\/TCR-alphabeta(+) large granular lymphocytes: utility in assessing clonality and insights into the pathogenesis of the disease. Am J Pathol. 2001;159: 1861-1868.","DOI":"10.1016\/S0002-9440(10)63032-5"},{"key":"2020021215293697000_REF41","doi-asserted-by":"crossref","unstructured":"Greer JP, Kinney MC, Loughran TP Jr. T cell and NK cell lymphoproliferative disorders. In: Hematology. Washington, DC; American Society of Hematology; 2001; 259-281.","DOI":"10.1182\/asheducation-2001.1.259"},{"key":"2020021215293697000_REF42","doi-asserted-by":"crossref","unstructured":"Bowman SJ, Hall MA, Panayi GS, Lanchbury JS. T cell receptor alpha-chain and beta-chain junctional region homology in clonal CD3+, CD8+ T lymphocyte expansions in Felty's syndrome. Arthritis Rheum. 1997;40: 615-623.","DOI":"10.1002\/art.1780400405"},{"key":"2020021215293697000_REF43","doi-asserted-by":"crossref","unstructured":"Kwong YL, Wong KF. Association of pure red cell aplasia with T large granular lymphocyte leukaemia. J Clin Pathol. 1998;51: 672-675.","DOI":"10.1136\/jcp.51.9.672"},{"key":"2020021215293697000_","doi-asserted-by":"crossref","unstructured":"Ergas D, Tsimanis A, Shtalrid M, Duskin C, Berrebi A. T-gamma large granular lymphocyte leukemia associated with amegakaryocytic thrombocytopenic purpura, Sjogren's syndrome, and polyglandular autoimmune syndrome type II, with subsequent development of pure red cell aplasia. Am J Hematol. 2002;69: 132-134.","DOI":"10.1002\/ajh.10024"},{"key":"2020021215293697000_REF45","doi-asserted-by":"crossref","unstructured":"Go RS, Lust JA, Phyliky RL. Aplastic anemia and pure red cell aplasia associated with large granular lymphocyte leukemia. Semin Hematol. 2003;40: 196-200.","DOI":"10.1016\/S0037-1963(03)00140-9"},{"key":"2020021215293697000_","doi-asserted-by":"crossref","unstructured":"Sood R, Stewart CC, Aplan PD, et al. Neutropenia associated with T-cell large granular lymphocyte leukemia: long-term response to cyclosporine therapy despite persistence of abnormal cells. Blood. 1998;91: 3372-3378.","DOI":"10.1182\/blood.V91.9.3372"},{"key":"2020021215293697000_REF47","doi-asserted-by":"crossref","unstructured":"Starkebaum G, Loughran TP Jr, Gaur LK, Davis P, Nepom BS. Immunogenetic similarities between patients with Felty's syndrome and those with clonal expansions of large granular lymphocytes in rheumatoid arthritis. Arthritis Rheum. 1997;40: 624-626.","DOI":"10.1002\/art.1780400406"},{"key":"2020021215293697000_REF48","doi-asserted-by":"crossref","unstructured":"Liu JH, Wei S, Lamy T, et al. Blockade of Fasdependent apoptosis by soluble Fas in LGL leukemia. Blood. 2002;100: 1449-1453.","DOI":"10.1182\/blood.V100.4.1449.h81602001449_1449_1453"},{"key":"2020021215293697000_REF49","doi-asserted-by":"crossref","unstructured":"Tanaka M, Suda T, Haze K, et al. Fas ligand in human serum. Nat Med. 1996;2: 317-322.","DOI":"10.1038\/nm0396-317"},{"key":"2020021215293697000_REF50","doi-asserted-by":"crossref","unstructured":"Epling-Burnette PK, Liu JH, Catlett-Falcone R, et al. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J Clin Invest. 2001;107: 351-362.","DOI":"10.1172\/JCI9940"},{"key":"2020021215293697000_REF51","doi-asserted-by":"crossref","unstructured":"Epling-Burnette PK, Loughran TP Jr. Survival signals in leukemic large granular lymphocytes. Semin Hematol. 2003;40: 213-220.","DOI":"10.1016\/S0037-1963(03)00135-5"},{"key":"2020021215293697000_REF52","doi-asserted-by":"crossref","unstructured":"Melenhorst JJ, Sorbara L, Kirby M, Hensel NF, Barrett AJ. Large granular lymphocyte leukaemia is characterized by a clonal T-cell receptor rearrangement in both memory and effector CD8(+) lymphocyte populations. Br J Haematol. 2001;112: 189-194.","DOI":"10.1046\/j.1365-2141.2001.02509.x"},{"key":"2020021215293697000_REF53","doi-asserted-by":"crossref","unstructured":"Kook H, Risitano AM, Zeng W, et al. Changes in T-cell receptor VB repertoire in aplastic anemia: effects of different immunosuppressive regimens. Blood. 2002;99: 3668-3675.","DOI":"10.1182\/blood.V99.10.3668"},{"key":"2020021215293697000_REF54","doi-asserted-by":"crossref","unstructured":"Hingorani R, Monteiro J, Furie R, et al. Oligoclonality of V beta 3 TCR chains in the CD8+ T cell population of rheumatoid arthritis patients. J Immunol. 1996;156: 852-858.","DOI":"10.4049\/jimmunol.156.2.852"},{"key":"2020021215293697000_","doi-asserted-by":"crossref","unstructured":"Gonzalez-Quintial R, Baccala R, Pope RM, Theofilopoulos AN. Identification of clonally expanded T cells in rheumatoid arthritis using a sequence enrichment nuclease assay. J Clin Invest. 1996;97: 1335-1343.","DOI":"10.1172\/JCI118550"},{"key":"2020021215293697000_","doi-asserted-by":"crossref","unstructured":"Hafler DA, Duby AD, Lee SJ, et al. Oligoclonal T lymphocytes in the cerebrospinal fluid of patients with multiple sclerosis. J Exp Med. 1988;167: 1313-1322.","DOI":"10.1084\/jem.167.4.1313"},{"key":"2020021215293697000_REF57","doi-asserted-by":"crossref","unstructured":"Monteiro J, Hingorani R, Peroglizzi R, Apatoff B, Gregersen PK. Oligoclonality of CD8+ T cells in multiple sclerosis. Autoimmunity. 1996;23: 127-138.","DOI":"10.3109\/08916939608995336"},{"key":"2020021215293697000_REF58","doi-asserted-by":"crossref","unstructured":"Akashi K, Shibuya T, Taniguchi S, et al. Multiple autoimmune haemopoietic disorders and insidious clonal proliferation of large granular lymphocytes. Br J Haematol. 1999;107: 670-673.","DOI":"10.1046\/j.1365-2141.1999.01734.x"},{"key":"2020021215293697000_REF59","doi-asserted-by":"crossref","unstructured":"Bowman SJ, Bhavnani M, Geddes GC, et al. Large granular lymphocyte expansions in patients with Felty's syndrome: analysis using anti-T cell receptor V beta-specific monoclonal antibodies. Clin Exp Immunol. 1995;101: 18-24.","DOI":"10.1111\/j.1365-2249.1995.tb02271.x"},{"key":"2020021215293697000_REF60","unstructured":"Molad Y, Okon E, Stark P, Prokocimer M. Sjogren's syndrome associated T cell large granular lymphocyte leukemia: a possible common etiopathogenesis. J Rheumatol. 2001;28: 2551-2552."},{"key":"2020021215293697000_REF61","doi-asserted-by":"crossref","unstructured":"Trentin L, Imberti L, Zambello R, et al. Detection of identical T-cell clonotype expansions in both the donor and recipient after allogeneic bone marrow transplantation. Br J Haematol. 1999;106: 119-127.","DOI":"10.1046\/j.1365-2141.1999.01512.x"},{"key":"2020021215293697000_REF62","doi-asserted-by":"crossref","unstructured":"Matsutani T, Yoshioka T, Tsuruta Y, et al. Determination of T-cell receptors of clonal CD8-positive T-cells in myelodysplastic syndrome with erythroid hypoplasia. Leuk Res. 2003;27: 305-312.","DOI":"10.1016\/S0145-2126(02)00173-X"},{"key":"2020021215293697000_REF63","doi-asserted-by":"crossref","unstructured":"O'Keefe CL, Plasilova M, Wlodarski M, et al. Molecular analysis of TCR clonotypes in LGL: a clonal model for polyclonal responses. J Immunol. 2004;172: 1960-1969.","DOI":"10.4049\/jimmunol.172.3.1960"},{"key":"2020021215293697000_REF64","doi-asserted-by":"crossref","unstructured":"Semenzato G, Zambello R, Starkebaum G, Oshimi K, Loughran TP Jr. The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis. Blood. 1997;89: 256-260.","DOI":"10.1182\/blood.V89.1.256"},{"key":"2020021215293697000_REF65","doi-asserted-by":"crossref","unstructured":"Herling M, Khoury JD, Washington LT, et al. A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories. Blood. 2004;104: 328-335.","DOI":"10.1182\/blood-2004-01-0002"},{"key":"2020021215293697000_REF66","doi-asserted-by":"crossref","unstructured":"Starkebaum G. Chronic neutropenia associated with autoimmune disease. Semin Hematol. 2002;39: 121-127.","DOI":"10.1053\/shem.2002.31918"},{"key":"2020021215293697000_REF67","doi-asserted-by":"crossref","unstructured":"Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 1982;51: 189-199.","DOI":"10.1111\/j.1365-2141.1982.tb08475.x"},{"key":"2020021215293697000_REF68","doi-asserted-by":"crossref","unstructured":"van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98\u20133936. Leukemia. 2003;17: 2257-2317.","DOI":"10.1038\/sj.leu.2403202"},{"key":"2020021215293697000_REF69","unstructured":"Lefranc M-P, Lefranc G. The T cell receptor FactsBook. London, UK: Academic Press; 2001."},{"key":"2020021215293697000_REF70","unstructured":"The International Immunogenetics Information System. IMGT\/V-QUEST. http:\/\/imgt.cines.fr\/cgi-bin\/IMGTdnap.jv?livret=0&Option=humanTcR. Accessed April 2004."},{"key":"2020021215293697000_REF71","unstructured":"The International Immunogenetics Information System. http:\/\/imgt.cines.fr\/. Accessed April 2004."},{"key":"2020021215293697000_REF72","unstructured":"Stryer L. Biochemistry. 3rd ed. New York, NY: W. H. Freeman and Company; 1988."},{"key":"2020021215293697000_REF73","doi-asserted-by":"crossref","unstructured":"McFarland EJ, Harding PA, Striebich CC, MaWhinney S, Kuritzkes DR, Kotzin BL. Clonal CD8+ T cell expansions in peripheral blood from human immunodeficiency virus type 1-infected children. J Infect Dis. 2002;186: 477-485.","DOI":"10.1086\/341939"},{"key":"2020021215293697000_REF74","doi-asserted-by":"crossref","unstructured":"Beck RC, Wlodarski M, Gondek L, et al. Efficient identification of T-cell clones associated with graft-versus-host disease in target tissue allows for subsequent detection in peripheral blood. Br J Haematol. 2005;129: 411-419.","DOI":"10.1111\/j.1365-2141.2005.05472.x"},{"key":"2020021215293697000_REF75","doi-asserted-by":"crossref","unstructured":"Davey MP, Starkebaum G, Loughran TP Jr. CD3+ leukemic large granular lymphocytes utilize diverse T-cell receptor V beta genes. Blood. 1995;85: 146-150.","DOI":"10.1182\/blood.V85.1.146.bloodjournal851146"},{"key":"2020021215293697000_REF76","doi-asserted-by":"crossref","unstructured":"Dhodapkar MV, Li CY, Lust JA, Tefferi A, Phyliky RL. Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance? Blood. 1994;84: 1620-1627.","DOI":"10.1182\/blood.V84.5.1620.1620"},{"key":"2020021215293697000_REF77","doi-asserted-by":"crossref","unstructured":"Kjer-Nielsen L, Clements CS, Purcell AW, et al. A structural basis for the selection of dominant alphabeta T cell receptors in antiviral immunity. Immunity. 2003;18: 53-64.","DOI":"10.1016\/S1074-7613(02)00513-7"},{"key":"2020021215293697000_REF78","doi-asserted-by":"crossref","unstructured":"Tobin G, Thunberg U, Karlsson K, et al. Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. Blood. 2004;104: 2879-2885.","DOI":"10.1182\/blood-2004-01-0132"},{"key":"2020021215293697000_REF79","doi-asserted-by":"crossref","unstructured":"Tomiyama H, Yamada N, Komatsu H, Hirayama K, Takiguchi M. A single CTL clone can recognize a naturally processed HIV-1 epitope presented by two different HLA class I molecules. Eur J Immunol. 2000;30: 2521-2530.","DOI":"10.1002\/1521-4141(200009)30:9<2521::AID-IMMU2521>3.0.CO;2-Q"},{"key":"2020021215293697000_REF80","unstructured":"European Bioinformatics Institute. ClustalW. http:\/\/www.ebi.ac.uk\/clustalw\/. Accessed April 2004."},{"key":"2020021215293697000_REF81","doi-asserted-by":"crossref","unstructured":"Mohty M, Faucher C, Vey N, et al. Features of large granular lymphocytes (LGL) expansion following allogeneic stem cell transplantation: a long-term analysis. Leukemia. 2002;16: 2129-2133.","DOI":"10.1038\/sj.leu.2402645"},{"key":"2020021215293697000_REF82","doi-asserted-by":"crossref","unstructured":"Au WY, Lam CC, Lie AK, Pang A, Kwong YL. T-cell large granular lymphocyte leukemia of donor origin after allogeneic bone marrow transplantation. Am J Clin Pathol. 2003;120: 626-630.","DOI":"10.1309\/VA755A03PVRV9XDT"},{"key":"2020021215293697000_REF83","doi-asserted-by":"crossref","unstructured":"Goulmy E, Pool J, van den Elsen PJ. Interindividual conservation of T-cell receptor beta chain variable regions by minor histocompatibility antigen-specific HLA-A*0201-restricted cytotoxic T-cell clones. Blood. 1995;85: 2478-2481.","DOI":"10.1182\/blood.V85.9.2478.bloodjournal8592478"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/8\/2769\/1635624\/zh802005002769.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/8\/2769\/1635624\/zh802005002769.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T07:57:26Z","timestamp":1683100646000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/106\/8\/2769\/21819\/Pathologic-clonal-cytotoxic-Tcell-responses"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,15]]},"references-count":83,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,10,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2004-10-4045","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,15]]}}}